Literature DB >> 26411364

CPEB1 mediates epithelial-to-mesenchyme transition and breast cancer metastasis.

K Nagaoka1, K Fujii1, H Zhang1, K Usuda1, G Watanabe1, M Ivshina2, J D Richter2.   

Abstract

In mouse mammary epithelial cells, cytoplasmic polyadenylation element binding protein 1 (CPEB1) mediates the apical localization of ZO-1 mRNA, which encodes a critical tight junction component. In mice lacking CPEB1 and in cultured cells from which CPEB has been depleted, randomly distributed ZO-1 mRNA leads to the loss of cell polarity. We have investigated whether this diminution of polarity results in an epithelial-to-mesenchyme (EMT) transition and possible increased metastatic potential. Here, we show that CPEB1-depleted mammary epithelial cells alter their gene expression profile in a manner consistent with an EMT and also become motile, which are made particularly robust when cells are treated with transforming growth factor-β, an enhancer of EMT. CPEB1-depleted mammary cells become metastatic to the lung following injection into mouse fat pads while ectopically expressed CPEB1 prevents metastasis. Surprisingly, CPEB1 depletion causes some EMT/metastasis-related mRNAs to have shorter poly(A) tails while other mRNAs to have longer poly(A) tails. Matrix metalloproteinase 9 (MMP9) mRNA, which encodes a metastasis-promoting factor, undergoes poly(A) lengthening and enhanced translation upon CPEB reduction. Moreover, in human breast cancer cells that become progressively more metastatic, CPEB1 is reduced while MMP9 becomes more abundant. These data suggest that at least in part, CPEB1 regulation of MMP9 mRNA expression mediates metastasis of breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26411364      PMCID: PMC4809797          DOI: 10.1038/onc.2015.350

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  40 in total

1.  Bidirectional control of mRNA translation and synaptic plasticity by the cytoplasmic polyadenylation complex.

Authors:  Tsuyoshi Udagawa; Sharon A Swanger; Koichi Takeuchi; Jong Heon Kim; Vijayalaxmi Nalavadi; Jihae Shin; Lori J Lorenz; R Suzanne Zukin; Gary J Bassell; Joel D Richter
Journal:  Mol Cell       Date:  2012-06-21       Impact factor: 17.970

Review 2.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

3.  Opposing polymerase-deadenylase activities regulate cytoplasmic polyadenylation.

Authors:  Jong Heon Kim; Joel D Richter
Journal:  Mol Cell       Date:  2006-10-20       Impact factor: 17.970

4.  Control of cellular senescence by CPEB.

Authors:  Irina Groisman; Maria Ivshina; Veronica Marin; Norman J Kennedy; Roger J Davis; Joel D Richter
Journal:  Genes Dev       Date:  2006-10-01       Impact factor: 11.361

5.  CPEB1 promotes differentiation and suppresses EMT in mammary epithelial cells.

Authors:  Ewa Grudzien-Nogalska; Brent C Reed; Robert E Rhoads
Journal:  J Cell Sci       Date:  2014-03-14       Impact factor: 5.285

6.  CPEB control of NF-kappaB nuclear localization and interleukin-6 production mediates cellular senescence.

Authors:  Rachel Groppo; Joel D Richter
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

7.  Specific miRNA stabilization by Gld2-catalyzed monoadenylation.

Authors:  Andrea D'Ambrogio; Weifeng Gu; Tsuyoshi Udagawa; Craig C Mello; Joel D Richter
Journal:  Cell Rep       Date:  2012-11-29       Impact factor: 9.423

Review 8.  Signaling mechanisms of the epithelial-mesenchymal transition.

Authors:  David M Gonzalez; Damian Medici
Journal:  Sci Signal       Date:  2014-09-23       Impact factor: 8.192

9.  Cytoplasmic polyadenylation element binding protein deficiency stimulates PTEN and Stat3 mRNA translation and induces hepatic insulin resistance.

Authors:  Ilya M Alexandrov; Maria Ivshina; Dae Young Jung; Randall Friedline; Hwi Jin Ko; Mei Xu; Bryan O'Sullivan-Murphy; Rita Bortell; Yen-Tsung Huang; Fumihiko Urano; Jason K Kim; Joel D Richter
Journal:  PLoS Genet       Date:  2012-01-12       Impact factor: 5.917

10.  Genetic and acute CPEB1 depletion ameliorate fragile X pathophysiology.

Authors:  Tsuyoshi Udagawa; Natalie G Farny; Mira Jakovcevski; Hanoch Kaphzan; Juan Marcos Alarcon; Shobha Anilkumar; Maria Ivshina; Jessica A Hurt; Kentaro Nagaoka; Vijayalaxmi C Nalavadi; Lori J Lorenz; Gary J Bassell; Schahram Akbarian; Sumantra Chattarji; Eric Klann; Joel D Richter
Journal:  Nat Med       Date:  2013-10-20       Impact factor: 53.440

View more
  35 in total

1.  Translational control of gurken mRNA in Drosophila development.

Authors:  Christopher J Derrick; Timothy T Weil
Journal:  Cell Cycle       Date:  2016-11-14       Impact factor: 4.534

Review 2.  Processing body (P-body) and its mediators in cancer.

Authors:  Bernard Nsengimana; Faiz Ali Khan; Ebenezeri Erasto Ngowi; Xuefeng Zhou; Yu Jin; Yuting Jia; Wenqiang Wei; Shaoping Ji
Journal:  Mol Cell Biochem       Date:  2022-01-28       Impact factor: 3.396

3.  Human bone marrow mesenchymal stem cell-derived exosomes containing microRNA-425 promote migration, invasion and lung metastasis by down-regulating CPEB1.

Authors:  Guoqiang Wang; Xiuli Ji; Pan Li; Wei Wang
Journal:  Regen Ther       Date:  2022-04-25       Impact factor: 3.651

4.  Survival stratification for colorectal cancer via multi-omics integration using an autoencoder-based model.

Authors:  Hu Song; Chengwei Ruan; Yixin Xu; Teng Xu; Ruizhi Fan; Tao Jiang; Meng Cao; Jun Song
Journal:  Exp Biol Med (Maywood)       Date:  2021-12-14

Review 5.  Cancer the'RBP'eutics-RNA-binding proteins as therapeutic targets for cancer.

Authors:  Shakur Mohibi; Xinbin Chen; Jin Zhang
Journal:  Pharmacol Ther       Date:  2019-07-11       Impact factor: 12.310

Review 6.  RNA-Binding Proteins Hold Key Roles in Function, Dysfunction, and Disease.

Authors:  Sophia Kelaini; Celine Chan; Victoria A Cornelius; Andriana Margariti
Journal:  Biology (Basel)       Date:  2021-04-24

Review 7.  Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker Development.

Authors:  Christos Vaklavas; Scott W Blume; William E Grizzle
Journal:  Front Oncol       Date:  2017-07-26       Impact factor: 6.244

8.  Hypoxia-induced changes in intragenic DNA methylation correlate with alternative splicing in breast cancer.

Authors:  Deepak Pant; Sathiya Pandi Narayanan; Nagarjun Vijay; Sanjeev Shukla
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

9.  CPEB1 restrains proliferation of Glioblastoma cells through the regulation of p27(Kip1) mRNA translation.

Authors:  Silvia Galardi; Massimo Petretich; Guillaume Pinna; Silvia D'Amico; Fabrizio Loreni; Alessandro Michienzi; Irina Groisman; Silvia Anna Ciafrè
Journal:  Sci Rep       Date:  2016-05-04       Impact factor: 4.379

10.  Altered splicing leads to reduced activation of CPEB3 in high-grade gliomas.

Authors:  Magdalena Skubal; Gerrit H Gielen; Anke Waha; Marco Gessi; Lech Kaczmarczyk; Gerald Seifert; Dorothee Freihoff; Johannes Freihoff; Torsten Pietsch; Matthias Simon; Martin Theis; Christian Steinhäuser; Andreas Waha
Journal:  Oncotarget       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.